The increase in mean IGFBP-1 and adiponectin levels 1 year after RYGB to normal levels suggest reduced hepatic inuslin resistance, improved insulin sensitivity and protection against future prediabetes and/or T2DM in those with normal glucose levels and prediabetes12,42,43. The gene discussed is IGFBP1; the disease is prediabetes syndrome.